Anton Wellstein

12.0k total citations · 1 hit paper
223 papers, 9.4k citations indexed

About

Anton Wellstein is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Anton Wellstein has authored 223 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Molecular Biology, 60 papers in Oncology and 59 papers in Cell Biology. Recurrent topics in Anton Wellstein's work include Fibroblast Growth Factor Research (49 papers), Proteoglycans and glycosaminoglycans research (42 papers) and Receptor Mechanisms and Signaling (28 papers). Anton Wellstein is often cited by papers focused on Fibroblast Growth Factor Research (49 papers), Proteoglycans and glycosaminoglycans research (42 papers) and Receptor Mechanisms and Signaling (28 papers). Anton Wellstein collaborates with scholars based in United States, Germany and China. Anton Wellstein's co-authors include Anna T. Riegel, Sandra W. McLeskey, Frank Czubayko, Achim Aigner, Gerald E. Stoica, Anke M. Schulte, Ronald Reiter, D. Palm, Emma T. Bowden and Angera H. Kuo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Anton Wellstein

219 papers receiving 9.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibroblast growth factors, their receptors and signaling.

2000 1.1k citations Anton Wellstein et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Anton Wellstein	6.1k	2.1k	2.1k	1.6k	1.2k	223	9.4k
Ellen Van Obberghen‐Schilling	6.3k 1.0×	1.2k 0.6×	1.5k 0.7×	1.2k 0.8×	886 0.7×	193	10.3k
Gilles Pagès	7.2k 1.2×	2.2k 1.1×	1.1k 0.5×	2.1k 1.3×	662 0.5×	173	11.3k
Lothar Schweigerer	5.5k 0.9×	1.4k 0.7×	1.2k 0.6×	1.5k 0.9×	1.2k 1.0×	87	9.5k
Marcelo G. Kazanietz	9.9k 1.6×	2.0k 0.9×	2.3k 1.1×	1.1k 0.7×	602 0.5×	192	13.2k
Ambra Pozzi	4.0k 0.7×	1.3k 0.6×	1.4k 0.7×	1.4k 0.9×	734 0.6×	173	8.5k
Catherine Tomasetto	5.3k 0.9×	1.4k 0.7×	1.2k 0.6×	1.5k 0.9×	926 0.8×	148	9.9k
Edward Y. Skolnik	7.5k 1.2×	1.6k 0.8×	2.1k 1.0×	668 0.4×	724 0.6×	84	11.2k
Alfonso Bellacosa	10.8k 1.8×	4.0k 1.9×	1.1k 0.5×	2.3k 1.4×	1.1k 0.9×	118	14.4k
Rebecca Taub	6.4k 1.1×	2.2k 1.1×	929 0.4×	1.3k 0.8×	1.4k 1.1×	165	15.6k
Sylvain Meloche	7.3k 1.2×	1.9k 0.9×	1.1k 0.5×	1.3k 0.8×	507 0.4×	151	10.6k

Countries citing papers authored by Anton Wellstein

Since Specialization

Citations

This map shows the geographic impact of Anton Wellstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Wellstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Wellstein more than expected).

Fields of papers citing papers by Anton Wellstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Wellstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Wellstein. The network helps show where Anton Wellstein may publish in the future.

Co-authorship network of co-authors of Anton Wellstein

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Wellstein. A scholar is included among the top collaborators of Anton Wellstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Wellstein. Anton Wellstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eiseler, Tim, et al.. (2025). Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokines. Journal for ImmunoTherapy of Cancer. 13(1). e010579–e010579. 7 indexed citations

Wellstein, Anton, et al.. (2025). Targeting TEAD in cancer. Frontiers in Oncology. 15. 1692512–1692512.

Jain, Sidharth, et al.. (2024). The Role of Aging and Senescence in Immune Checkpoint Inhibitor Response and Toxicity. International Journal of Molecular Sciences. 25(13). 7013–7013. 3 indexed citations

Matías‐Guiu, Xavier, Yuichiro Tsukada, Gerry Melino, et al.. (2024). Tumor specimen cold ischemia time impacts molecular cancer drug target discovery. Cell Death and Disease. 15(9). 691–691. 3 indexed citations

Ganguly, Debolina, Marcel O. Schmidt, Noah Sorrelle, et al.. (2023). Pleiotrophin drives a prometastatic immune niche in breast cancer. The Journal of Experimental Medicine. 220(5). 8 indexed citations

Loyfer, Netanel, Marcel O. Schmidt, Sidharth Jain, et al.. (2023). Circulating cell-free methylated DNA reveals tissue-specific, cellular damage from radiation treatment. JCI Insight. 8(14). 6 indexed citations

Schmidt, Marcel O., et al.. (2023). Stromal Senescence following Treatment with the CDK4/6 Inhibitor Palbociclib Alters the Lung Metastatic Niche and Increases Metastasis of Drug-Resistant Mammary Cancer Cells. Cancers. 15(6). 1908–1908. 13 indexed citations

Campbell, Moray J., Surojeet Sengupta, Garrett T. Graham, et al.. (2021). An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer. Cancer Research. 81(16). 4230–4241. 10 indexed citations

Graham, Garrett T., et al.. (2019). Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast Cancer. Molecular Cancer Therapeutics. 18(12). 2220–2232. 7 indexed citations

10.

Ory, Virginie, Garrett T. Graham, Meng Yuan, et al.. (2019). Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression. EMBO Reports. 21(1). e48741–e48741. 16 indexed citations

11.

Fereshteh, Mark, Maddalena T. Tilli, Sung Eun Kim, et al.. (2008). The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice. Cancer Research. 68(10). 3697–3706. 82 indexed citations

12.

Lahusen, Tyler, Mark Fereshteh, Annabell S. Oh, Anton Wellstein, & Anna T. Riegel. (2007). Epidermal Growth Factor Receptor Tyrosine Phosphorylation and Signaling Controlled by a Nuclear Receptor Coactivator, Amplified in Breast Cancer 1. Cancer Research. 67(15). 7256–7265. 55 indexed citations

13.

Ray, Patricio E., E. ̃Tassi, Xuehui Liu, & Anton Wellstein. (2005). Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndrome. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 290(1). R105–R113. 31 indexed citations

14.

Stoica, Gerald E., Thomas Franke, Maria Moroni, et al.. (2003). Effect of estradiol on estrogen receptor-α gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. Oncogene. 22(39). 7998–8011. 142 indexed citations

15.

Juhl, Hartmut, et al.. (1997). HER-2/neu Is Rate-limiting for Ovarian Cancer Growth. Journal of Biological Chemistry. 272(47). 29482–29486. 56 indexed citations

16.

Wellstein, Anton & Frank Czubayko. (1996). Inhibition of fibroblast growth factors. Breast Cancer Research and Treatment. 38(1). 109–119. 24 indexed citations

17.

Marshall, J L, et al.. (1994). PHASE 1 TRIAL OF ORALLY ADMINISTERED PENTOSAN POLYSULPHATE (PPS) IN PATIENTS WITH ADVANCED MALIGNANCIES. Journal of Immunotherapy. 16(3). 249–249. 2 indexed citations

18.

Li, Ming, Robert P. Yasuda, S J Wall, Anton Wellstein, & Barry B. Wolfe. (1991). Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.. Molecular Pharmacology. 40(1). 28–35. 99 indexed citations

19.

Blume, Howard W., et al.. (1978). [Clinical and laboratory aspects of malignant hyperthermia in children with special reference to creatine kinase isoenzymes (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(3). 108–14. 2 indexed citations

20.

Wellstein, Anton, et al.. (1977). [Creatine kinase isoenzyme MB and CK/GOT-ratio in the differential diagnosis of acute myocardial infarction (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 72(35). 1368–71. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact